Cargando…
Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation
Glucocorticoid-induced osteoporosis (GIO) is one of the major side effects of long-term glucocorticoid (GC) therapy mediated mainly via the suppression of bone formation and osteoblast differentiation independently of GC receptor (GR) dimerization. Since microRNAs play a critical role in osteoblast...
Autores principales: | Liu, Peng, Baumgart, Mario, Groth, Marco, Wittmann, Jürgen, Jäck, Hans-Martin, Platzer, Matthias, Tuckermann, Jan P., Baschant, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995469/ https://www.ncbi.nlm.nih.gov/pubmed/27554624 http://dx.doi.org/10.1038/srep32112 |
Ejemplares similares
-
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015) -
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice
por: Deken, Marcel A., et al.
Publicado: (2016) -
Mast cell-specific Cre/loxP-mediated recombination in vivo
por: Scholten, Julia, et al.
Publicado: (2007) -
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022) -
Differentiation Capacity of Bone Marrow-Derived Rat Mesenchymal Stem Cells from DsRed and Cre Transgenic Cre/loxP Models
por: Tseng, Hsiang-Ching, et al.
Publicado: (2022)